Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion type Assertion NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_head.
- NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion description "[So we believe that the elimination of the immunogenicity of CAR might prolong the persistence of CAR expressing T cells in vivo and put forward a hypothesis that the antigen binding portion of CAR could be derived from the antibody against osteosarcoma antigen from the same patient with osteosarcoma by methods such as antibody phage display, BRASIL technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_provenance.
- NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion evidence source_evidence_literature NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_provenance.
- NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion SIO_000772 22330890 NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_provenance.
- NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion wasDerivedFrom befree-20140225 NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_provenance.
- NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_assertion wasGeneratedBy ECO_0000203 NP310239.RARCJ0I5Y1dK20-RpB2xrV-1bw266Xal5LGmcgZ6MHMAo130_provenance.